Completed PHASE1 INTERVENTIONAL 2-arm NCT04171258

Clinical Trial to Compare the Safety and Efficacy of Botulax® Versus Botox® in Patients With Cervical Dystonia

A Multi-center, Double-blind, Randomized, Parallel, Active-controlled, Phase I Clinical Trial to Compare the Safety and Efficacy of Botulax® Versus Botox® in Patients With Cervical Dystonia

Sponsor: Hugel

Conditions Cervical Dystonia

Interventions Botulinum Toxin Type A Injection [Botox] Botulinum toxin type A injection

Updated 9 times since 2019 Last updated: Apr 14, 2022 Started: May 26, 2020 Primary completion: Apr 26, 2021 Completion: Oct 26, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1 clinical study on Cervical Dystonia, this trial is completed. The trial is conducted by Hugel and has accumulated 9 data snapshots since 2020. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

9 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE1
Sep 2024 — Sep 2025 [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
May 2022 — Jul 2024 [monthly]

Completed PHASE1

Status: Unknown Status → Completed
Oct 2021 — May 2022 [monthly]

Unknown Status PHASE1

Status: Not Yet Recruiting → Unknown Status

▶ Show 4 earlier versions

Jan 2021 — Oct 2021 [monthly]

Not Yet Recruiting PHASE1
Mar 2020 — Jan 2021 [monthly]

Not Yet Recruiting PHASE1
Feb 2020 — Mar 2020 [monthly]

Not Yet Recruiting PHASE1
Dec 2019 — Feb 2020 [monthly]

Not Yet Recruiting PHASE1

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hugel

Data source: Hugel

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Seoul, South Korea